ArticleInternational journal of MS care

Immune Response to Seasonal Influenza Vaccine in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Long-term Daclizumab Beta: A Prospective, Open-Label, Single-Arm Study.

Lahar Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.